D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 50 Citations 9,978 265 World Ranking 13059 National Ranking 5544

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Cancer

His main research concerns Cancer research, Cell biology, RNA interference, Signal transduction and Biochemistry. He has researched Cancer research in several fields, including Cancer cell, CD34 and Pharmacology. His Cell biology research includes elements of Exocytosis and Lysosome.

His research on RNA interference concerns the broader Genetics. His work deals with themes such as RNA, Interaction network and Transcription, which intersect with Signal transduction. His research on Endosome also deals with topics like

  • Flow cytometry which connect with High-throughput screening,
  • Secretion which is related to area like Molecular biology.

His most cited work include:

  • Genome-Scale RNAi Screen for Host Factors Required for HIV Replication (653 citations)
  • Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma (372 citations)
  • High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells (262 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Cancer research, Cell biology, High-throughput screening, Pharmacology and Molecular biology. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cancer, Metastasis, Cell culture and In vivo. He studies Signal transduction, a branch of Cell biology.

The High-throughput screening study combines topics in areas such as Computational biology and Small molecule. His work in Computational biology addresses issues such as RNA interference, which are connected to fields such as Bioinformatics. His Pharmacology research is multidisciplinary, incorporating perspectives in Agonist and Receptor.

He most often published in these fields:

  • Cancer research (26.67%)
  • Cell biology (16.08%)
  • High-throughput screening (14.51%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (26.67%)
  • In vivo (9.41%)
  • Cell biology (16.08%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cancer research, In vivo, Cell biology, Cancer cell and Agonist. His Cancer research study combines topics from a wide range of disciplines, such as Cell, Cell culture and Cancer, Ovarian cancer, Metastasis. His In vivo study also includes fields such as

  • In vitro which intersects with area such as Bioinformatics and Regenerative medicine,
  • Risk analysis most often made with reference to Drug discovery.

His Cell biology study integrates concerns from other disciplines, such as Dermis, Human skin and Spongiosis. His Cancer cell research incorporates elements of Autophagy, Pancreatic cancer, Immune system, Autolysosome and Perinucleolar compartment. His research in Agonist intersects with topics in Biophysics, Pharmacology, Small molecule and Innate immune system.

Between 2017 and 2021, his most popular works were:

  • High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer (73 citations)
  • MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma. (41 citations)
  • Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening (40 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Cancer

Marc Ferrer mostly deals with Cancer research, Cell biology, Cancer cell, Autophagy and Skin equivalent. The study incorporates disciplines such as Tipifarnib, Secretion, ESCRT, Receptor and High-throughput screening in addition to Cancer research. Marc Ferrer combines subjects such as PI3K/AKT/mTOR pathway, Signal transduction, Pediatric cancer and Carcinogenesis with his study of Receptor.

Marc Ferrer undertakes multidisciplinary studies into Cell biology and GPR32 in his work. His biological study spans a wide range of topics, including Cell culture, In vitro, Immune system and RNA polymerase. His studies deal with areas such as Gating, Electrophysiology and Membrane potential as well as Autophagy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Genome-Scale RNAi Screen for Host Factors Required for HIV Replication

Honglin Zhou;Min Xu;Qian Huang;Adam T. Gates.
Cell Host & Microbe (2008)

888 Citations

Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma

Yibin Yang;Arthur L. Shaffer;N.C. Tolga Emre;Michele Ceribelli.
Cancer Cell (2012)

527 Citations

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells

Lesley A. Mathews Griner;Rajarshi Guha;Paul Shinn;Ryan M. Young.
Proceedings of the National Academy of Sciences of the United States of America (2014)

365 Citations

MCOLN1 is a ROS sensor in lysosomes that regulates autophagy

Xiaoli Zhang;Xiping Cheng;Lu Yu;Junsheng Yang;Junsheng Yang.
Nature Communications (2016)

341 Citations

Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors

Anju Singh;Sreedhar Venkannagari;Kyu H. Oh;Ya Qin Zhang.
ACS Chemical Biology (2016)

294 Citations

Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides.

James R. Maiolo;Marc Ferrer;Elizabeth A. Ottinger.
Biochimica et Biophysica Acta (2005)

288 Citations

Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements

Marc Ferrer;Tarun M. Kapoor;Tim Strassmaier;Winfried Weissenhorn;Winfried Weissenhorn.
Nature Structural & Molecular Biology (1999)

234 Citations

A TRP Channel in the Lysosome Regulates Large Particle Phagocytosis via Focal Exocytosis

Mohammad Samie;Xiang Wang;Xiaoli Zhang;Andrew Goschka.
Developmental Cell (2013)

234 Citations

Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 Disruptions

Steven R. Bartz;Zhan Zhang;Julja Burchard;Maki Imakura.
Molecular and Cellular Biology (2006)

218 Citations

Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption

Wei-Qin Zhao;Francesca Santini;Robert Breese;Dave Ross.
Journal of Biological Chemistry (2010)

196 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marc Ferrer

Anton Simeonov

Anton Simeonov

National Institutes of Health

Publications: 37

Louis M. Staudt

Louis M. Staudt

National Institutes of Health

Publications: 31

George Barany

George Barany

University of Minnesota

Publications: 30

Wei Zheng

Wei Zheng

National Institutes of Health

Publications: 30

Nevan J. Krogan

Nevan J. Krogan

University of California, San Francisco

Publications: 23

Rajarshi Guha

Rajarshi Guha

Google (United States)

Publications: 22

Irwin M. Chaiken

Irwin M. Chaiken

Drexel University

Publications: 22

Tero Aittokallio

Tero Aittokallio

University of Helsinki

Publications: 22

Craig J. Thomas

Craig J. Thomas

National Institutes of Health

Publications: 22

Francesco Bertoni

Francesco Bertoni

Institute of Oncology Research

Publications: 21

Haoxing Xu

Haoxing Xu

University of Michigan–Ann Arbor

Publications: 19

Shibo Jiang

Shibo Jiang

Fudan University

Publications: 18

Ross A. D. Bathgate

Ross A. D. Bathgate

Florey Institute of Neuroscience and Mental Health

Publications: 17

Ruili Huang

Ruili Huang

National Institutes of Health

Publications: 16

Ülo Langel

Ülo Langel

Stockholm University

Publications: 14

William L. Klein

William L. Klein

Northwestern University

Publications: 14

Trending Scientists

Guo-Yu Yang

Guo-Yu Yang

Beijing Institute of Technology

Jiří Čejka

Jiří Čejka

Charles University

Wolfgang Baumann

Wolfgang Baumann

University of Rostock

Shin-Hyun Kim

Shin-Hyun Kim

Korea Advanced Institute of Science and Technology

Hugues Matile

Hugues Matile

Roche (Switzerland)

John M. Harlan

John M. Harlan

University of Washington

Wolfgang Kneifel

Wolfgang Kneifel

University of Natural Resources and Life Sciences

Peter H. Daum

Peter H. Daum

Brookhaven National Laboratory

Javier DeFelipe

Javier DeFelipe

Technical University of Madrid

Pablo E. Castillo

Pablo E. Castillo

Albert Einstein College of Medicine

Gerhard Walzl

Gerhard Walzl

Stellenbosch University

Sandra M. Chafouleas

Sandra M. Chafouleas

University of Connecticut

M. Lynne Cooper

M. Lynne Cooper

University of Missouri

Magdalena Cerdá

Magdalena Cerdá

New York University

Something went wrong. Please try again later.